Wayne State U and MITRI Partner to Move Neuro Rx Candidates to Clinical Trials

WSU and the Michigan Technology and Research Institute are seeking funding to form a company to shepherd to clinical trials WSU's first candidate, a triple uptake inhibitor for treating depression. They eventually hope to attract a pharma partner for further development.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.